Overview

Capsaicin for Cerebral Perfusion Augmentation.

Status:
Completed
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
To determine the safety and effect of crescent doses of capsaicin upon serial transcranial Doppler (TCD) markers of cerebral blood flow (CBF). Methods We performed serial TCD testing in 30 healthy volunteers divided into five equal groups. Capsaicin doses ranged from 33 to 165 μMol. We recorded peak systolic and end-diastolic velocities in the middle cerebral artery (MCA), arterial pressure, and perceived pungency (PP) in five minutes intervals up to 20 minutes. We then calculated the mean velocity (MV), the pulsatility index (PI), and the CBF index.
Phase:
Phase 1
Details
Lead Sponsor:
Juan Manuel Marquez Romero
Collaborators:
Centenario Hospital Miguel Hidalgo
Universidad de Guanajuato
Treatments:
Capsaicin